Interesting article to read!
Whilst autoimmunity in CFS may be considered a peripheral
phenomenon, it’s potential importance is highlighted by the recent Rituximab study
(B-lymphocyte depletion) which demonstrated significant therapeutic benefit 8. Putative factors
underpinning autoimmunity in CFS include oxidative stress, altered gut
permeability, chronic inflammation and chronic immune activation 3,9.